Researchers at The University of Texas MD Anderson Cancer Center have characterized cancer cell-specific features in the ...
Artificial intelligence is beginning to reshape how cancer treatment decisions are made. In a significant development, the ...
Biomarker testing identifies high-risk early-stage NSCLC patients for adjuvant chemotherapy, reducing recurrence risk by 78%. The AIM-HIGH study shows a 96% disease-free survival rate at 24 months ...
A home-infusion model combining remote physiologic monitoring, virtual command center supervision, and in-home nursing enabled delivery of 93 IV chemotherapy infusions without infusion reactions or ...
HealthShots on MSN
Do all breast cancer patients need chemotherapy?
The first question that most breast cancer patients ask is whether they will need chemotherapy. Their eyes are filled with ...
The mindfulness-based stress reduction group also showed a clear pattern of improvement over time, with both baseline and ...
Tagrisso plus chemotherapy improved progression-free survival in EGFR-positive NSCLC patients compared to placebo plus chemotherapy, with median survival of 8.4 vs. 4.4 months. Central nervous system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results